Filing Flows › Conmed (CNMD) › Q1 2025
Conmed (CNMD) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
Conmed (CNMD) reported revenue of $321M for the first quarter 2025 (Q1 2025), +3% from a year earlier and -7% from the quarter before. Operating margin was 5.0%, net earnings $6.0M (1.9% of revenue).
Conmed, Q1 2025: revenue $321M (+3% year over year), operating margin 5.0%, net earnings $6.0M, operating cash flow $41.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $321M | -7% | +3% |
| Gross profit | $178M | -10% | +3% |
| Operating profit | $16.0M | -70% | -54% |
| Net earnings | $6.0M | -82% | -69% |
| Operating cash flow | $41.5M | -4% | +43% |
| Free cash flow | $37.8M | -4% | +39% |
What changed
Revenue was $321.3M in Q1 2025, up 3% year over year and down 7% from the previous quarter. General Surgery was the largest line at 57% of revenue. General Surgery added $5.6M year over year (up 3%), 62% of the total change.
Gross margin was 55.3%, up 0.3 points from a year earlier. Operating profit was $16.0M, a 5.0% margin (down 6.2 points year over year). Operating profit fell $19.1M even though revenue rose $9.0M versus a year earlier, so costs grew faster than sales. Operating expenses grew 18% against revenue growth of 3%. The fastest-growing cost line was SG&A (+21%). Net earnings were $6.0M, down 69% year over year. The effective tax rate was 21.3%.
Operating cash flow was $41.5M (up 43% year over year), 688% of net earnings. Non-cash charges added back $12.9M of depreciation and amortization and $13.9M of share-based compensation. Working capital and other items added $8.7M. Capital expenditures of $3.8M left free cash flow of $37.8M.
Questions
What was Conmed's revenue in the first quarter 2025?
Conmed (CNMD) reported revenue of $321M for the first quarter 2025 (Q1 2025), +3% from a year earlier and -7% from the quarter before.
Was Conmed profitable in the first quarter 2025?
Operating profit was $16.0M (5.0% of revenue) and net earnings $6.0M.
Source: Conmed 10-Q on SEC EDGAR.